Atlas Trials

Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis

Clinical trial NCT02507570 · COMPLETED

Trial details

NCT number
NCT02507570
Sponsor
Carolina Research Professionals, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Carcinoma Metastatic to the Bone
Start date
2015-09-23
Primary completion
2019-01-18
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.